'Secondary chronic myeloid leukemia': comparison between patients previously exposed or not to chemo- and/or radiotherapy

Leuk Lymphoma. 2019 Dec;60(14):3584-3586. doi: 10.1080/10428194.2019.1639162. Epub 2019 Jul 11.

Authors

Francesco Autore¹, Federica Sorà¹, Patrizia Chiusolo¹, Mario Annunziata², Alessandra Iurlo³, Daniele Cattaneo³, Sara Galimberti⁴, Jolanta Alina Bajer¹, Simona Sica¹

Affiliations

¹ Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
² Cardarelli Hospital, Naples, Italy.
³ Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
⁴ University of Pisa, Pisa, Italy.

PMID: 31294653
DOI: 10.1080/10428194.2019.1639162

No abstract available

Publication types

Comparative Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Chemoradiotherapy / mortality*
Female
Follow-Up Studies
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Male
Middle Aged
Neoplasms, Second Primary / mortality*
Neoplasms, Second Primary / pathology
Neoplasms, Second Primary / therapy
Prognosis
Radiotherapy / mortality*
Retrospective Studies
Survival Rate